QQQ   417.37 (-1.43%)
AAPL   165.10 (-1.16%)
MSFT   399.92 (-1.08%)
META   483.53 (-3.64%)
GOOGL   153.94 (-1.33%)
AMZN   174.96 (-2.38%)
TSLA   149.36 (-0.38%)
NVDA   813.39 (-3.94%)
AMD   149.09 (-3.86%)
NIO   3.85 (-3.75%)
BABA   68.86 (-0.03%)
T   16.39 (+0.37%)
F   12.13 (+0.58%)
MU   107.54 (-3.92%)
GE   149.00 (-2.58%)
CGC   8.15 (+4.09%)
DIS   112.12 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   62.18 (+0.13%)
XOM   120.07 (+1.31%)
QQQ   417.37 (-1.43%)
AAPL   165.10 (-1.16%)
MSFT   399.92 (-1.08%)
META   483.53 (-3.64%)
GOOGL   153.94 (-1.33%)
AMZN   174.96 (-2.38%)
TSLA   149.36 (-0.38%)
NVDA   813.39 (-3.94%)
AMD   149.09 (-3.86%)
NIO   3.85 (-3.75%)
BABA   68.86 (-0.03%)
T   16.39 (+0.37%)
F   12.13 (+0.58%)
MU   107.54 (-3.92%)
GE   149.00 (-2.58%)
CGC   8.15 (+4.09%)
DIS   112.12 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   62.18 (+0.13%)
XOM   120.07 (+1.31%)
QQQ   417.37 (-1.43%)
AAPL   165.10 (-1.16%)
MSFT   399.92 (-1.08%)
META   483.53 (-3.64%)
GOOGL   153.94 (-1.33%)
AMZN   174.96 (-2.38%)
TSLA   149.36 (-0.38%)
NVDA   813.39 (-3.94%)
AMD   149.09 (-3.86%)
NIO   3.85 (-3.75%)
BABA   68.86 (-0.03%)
T   16.39 (+0.37%)
F   12.13 (+0.58%)
MU   107.54 (-3.92%)
GE   149.00 (-2.58%)
CGC   8.15 (+4.09%)
DIS   112.12 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   62.18 (+0.13%)
XOM   120.07 (+1.31%)
QQQ   417.37 (-1.43%)
AAPL   165.10 (-1.16%)
MSFT   399.92 (-1.08%)
META   483.53 (-3.64%)
GOOGL   153.94 (-1.33%)
AMZN   174.96 (-2.38%)
TSLA   149.36 (-0.38%)
NVDA   813.39 (-3.94%)
AMD   149.09 (-3.86%)
NIO   3.85 (-3.75%)
BABA   68.86 (-0.03%)
T   16.39 (+0.37%)
F   12.13 (+0.58%)
MU   107.54 (-3.92%)
GE   149.00 (-2.58%)
CGC   8.15 (+4.09%)
DIS   112.12 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   62.18 (+0.13%)
XOM   120.07 (+1.31%)
Free Trial
NASDAQ:PRVL

Prevail Therapeutics (PRVL) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free PRVL Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$23.00
▼
$23.00
50-Day Range
$22.91
▼
$23.20
52-Week Range
$9.02
▼
$23.35
Volume
N/A
Average Volume
955,800 shs
Market Capitalization
$787.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
PRVL stock logo

About Prevail Therapeutics Stock (NASDAQ:PRVL)

Prevail Therapeutics Inc., a gene therapy company, focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. The company's lead product candidate is PR001, which is in Phase I/II clinical trial for the treatment of Parkinson's disease with GBA1 mutation and neuronopathic Gaucher disease. It is also developing PR006 for the treatment of frontotemporal dementia with GRN mutation; and PR004 for the treatment of synucleinopathies. Prevail Therapeutics Inc. was founded in 2017 and is based in New York, New York.

PRVL Stock News Headlines

April 16, 2024 | tmcnet.com
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
April 16, 2024 | marketwatch.com
Precision BioSciences to Regain Programs After Prevail Team-Up Ends
April 19, 2024 | DTI (Ad)
With the “Bitcoin Loophole” you can supercharge the gains by 10x or more
Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…
April 2, 2024 | yahoo.com
New England Metal & Hardcore Fest 2024 Lineup: Killswitch Engage and Slaughter to Prevail
March 6, 2024 | msn.com
Halestorm Announce Co-Headlining Tour in 2024 with I Prevail
March 4, 2024 | msn.com
Halestorm + I Prevail Announce 2024 North American Summer Tour
February 5, 2024 | uk.movies.yahoo.com
Lori Kay Relaunches Management & Production Company Prevail Artist Entertainment
November 2, 2023 | yahoo.com
Primates Prevail in Teaser for Kingdom of the Planet of the Apes: Watch
April 19, 2024 | Paradigm Press (Ad)
Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
October 28, 2023 | ft.com
Humanity must prevail in Gaza
October 24, 2023 | msn.com
Insane Airflow, Impressively Durable: Specialized S-Works Prevail 3 Bike Helmet 1-Year Review
October 12, 2023 | msn.com
Prevail Bank in Wausau helping community grow
September 18, 2023 | finance.yahoo.com
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
July 25, 2023 | msn.com
Specialized/Fjallraven Prevail Helmet review: summery lid for bikepacking
July 18, 2023 | msn.com
Hard rock band Godsmack, with I Prevail, will play the Resch Center in September
May 19, 2023 | benzinga.com
BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share
May 9, 2023 | usnews.com
North Korea's Kim Says Russia 'Will Prevail' Over Hostile Forces
March 26, 2023 | abcnews.go.com
Abortion-rights supporters prevail in New Hampshire House
February 1, 2023 | msn.com
Novartis Ag (NVS) Q4 2022 Earnings Call Transcript
January 5, 2023 | forbes.com
Why Some Teams Fail And Others Prevail
January 5, 2023 | msn.com
Delhi Wakes Up To Chilling 3 Degrees, Season’s Lowest; Coldwave, Fog To Prevail In These States | Full Forecast
November 21, 2022 | msn.com
Prevail Bank makes donation to local teen homeless shelter
November 2, 2022 | seekingalpha.com
Vanda Pharmaceuticals Inc. (VNDA) Q3 2022 Earnings Call Transcript
November 1, 2022 | msn.com
Prevail Bank Eau Claire branch grand reopening
September 24, 2022 | news.yahoo.com
5 things to know from I Prevail's 'True Power' Tour stop in Lubbock
September 9, 2022 | yahoo.com
I Prevail Reflect on the Pandemic, ‘Trauma’ and New LP ‘True Power’
August 4, 2022 | msn.com
Prevail Bank donates funds for school supply drive
See More Headlines
Receive PRVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prevail Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2020
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PRVL
CUSIP
N/A
CIK
N/A
Web
www.prevailtherapeutics.com
Phone
917-336-9310
Fax
N/A
Employees
66
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($2.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-63,190,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-55.57%
Return on Assets
-48.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.56
Quick Ratio
7.56

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.85 per share
Price / Book
4.74

Miscellaneous

Outstanding Shares
34,246,000
Free Float
N/A
Market Cap
$787.66 million
Optionable
Not Optionable
Beta
1.59
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Asa Abeliovich M.D. (Age 56)
    Ph.D., Founder, Pres, CEO & Director
    Comp: $737.47k
  • Dr. Yong Dai Ph.D. (Age 49)
    Chief Technology Officer
    Comp: $450.62k
  • Dr. Jeffrey Sevigny M.D. (Age 51)
    Chief Medical Officer
    Comp: $593k
  • Dr. Brett Kaplan M.D. (Age 46)
    CFO & Sec.
  • Ms. Kira M. Schwartz
    Gen. Counsel
  • Ms. Emily Minkow (Age 37)
    Chief Bus. Officer
  • Dr. Franz F. Hefti Ph.D. (Age 72)
    Chief Devel. Officer

Key Competitors

View All Competitors

PRVL Stock Analysis - Frequently Asked Questions

How were Prevail Therapeutics' earnings last quarter?

Prevail Therapeutics Inc. (NASDAQ:PRVL) posted its quarterly earnings results on Friday, November, 13th. The company reported ($0.55) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.64) by $0.09.

What other stocks do shareholders of Prevail Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prevail Therapeutics investors own include Sorrento Therapeutics (SRNE), Alector (ALEC), Gossamer Bio (GOSS), Editas Medicine (EDIT), Harpoon Therapeutics (HARP), Atreca (BCEL), Precision BioSciences (DTIL), Fulcrum Therapeutics (FULC), Inovio Pharmaceuticals (INO) and Stoke Therapeutics (STOK).

When did Prevail Therapeutics IPO?

Prevail Therapeutics (PRVL) raised $126 million in an IPO on Thursday, June 20th 2019. The company issued 7,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

This page (NASDAQ:PRVL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
SHOCKING Crypto Leak…
Crypto 101 Media
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends